Advertisement
![Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px](/banner/iito-business-intelligence-20220406-650-100-promote-brand-to-decision-makers.jpg)
Collaboration › Details
Bruker–Cowen: investor conference, 202103 supply service Bruker presents at Cowen & Co Annual Health Care Conference 2021
![]() |
Period | 2021-03-02 |
![]() |
Partner, 1st | Bruker Corporation (Nasdaq: BRKR) |
Group | Bruker (Group) | |
Partner, 2nd | Cowen & Company LLC | |
Group | Cowen (Group) | |
![]() |
Product | Cowen & Co. Annual Health Care Conference 2021 DIGITAL |
Product 2 | analytical instrument | |
![]() |
Person | Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel) |
Person 2 | Minkova, Miroslava (Bruker Corp 201611 Head of Investor Relations) | |
Bruker Corporation. (2/22/21). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences:
10th Annual SVB Leerink Healthcare Conference
Thursday, February 25, 2021, at 8:40 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer
Cowen 41st Annual Health Care Conference
Tuesday, March 2, 2021, at 11:10 a.m. Eastern Time
Gerald Herman, Chief Financial Officer
Live audio webcasts of the virtual “fireside chat” sessions will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays will be posted on Bruker’s Investor Relations website after each event and will be available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
E: Investor.Reations@bruker.com
Record changed: 2022-01-02 |
Advertisement

More documents for Bruker (Group)
- [1] Bruker Corporation. (1/5/23). "Press Release: Bruker Announces Acquisition of Acquifer Imaging GmbH". Heidelberg....
- [2] Bruker Corporation. (1/4/23). "Press Release: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers". Lausanne....
- [3] Bruker Corporation. (12/21/22). "Press Release: Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference". Billerica, MA....
- [4] Bruker Corporation. (12/5/22). "Press Release: Bruker Completes the Acquisition of Neurescence Inc.". Billerica, MA....
- [5] Bruker Corporation. (11/14/22). "Press Release: Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio". Billerica, MA....
- [6] Bruker Corporation. (11/8/22). "Press Release: Bruker Announces Acquisition of Inscopix for Neuroscience Research". Mountain View, CA....
- [7] Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA....
- [8] Bruker Corporation. (5/10/22). "Press Release: Bruker and TOFwerk Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets". Thun....
- [9] Bruker Corporation. (5/9/22). "Press Release: Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets". London....
- [10] IonSense, Inc.. (4/7/22). "Press Release: IonSense, a Leader In DART Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development". New York, NY, London & Research Triangle Park, NC....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
» top